2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow PB: new trials by email Literature Review of PB trials Research Report on PB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension REGN7544, PB - Sepsis-Induced Hypotension | Phase 2 | Completed | Regeneron Pharmaceuticals | 76 | 2025-05-05 | 2026-05-20 |
| Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration PB - Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus | Phase 2 | Completed | Mayo Clinic | 36 | 2022-09-01 | 2026-01-27 |
Diabetes Insipidus (1) · Diabetes Insipidus, Nephrogenic (1) · Hypotension (1) · Polycystic Kidney Diseases (1) · Polycystic Kidney, Autosomal Dominant (1)
Mayo Clinic (1) · Regeneron Pharmaceuticals (1)
United States (2) · France (1)
Fouad Chebib, MD (1)